Visualizing Cellular Recycling

Lysosomes are the cell’s recycling centers. They break down unwanted material, help remove damaged cell parts, and rely on a specialized set of enzymes and membrane proteins to control transport, trafficking, and acidity. Beyond waste disposal, lysosomes also help cells sense and manage nutrients and energy, making them important for processes such as growth, stress responses, and survival. Different cell types have unique physiological functions, metabolic demands, and types of cellular waste to process. Rather than acting as uniform recycling centers, lysosomes customize their protein composition to support the distinct, specialized tasks of their host cell. The cell-type-specific composition (protein types and abundances) of lysosomes in the brain are especially poorly understood.

While lysosomal storage disorders (LSDs) are multi-systemic diseases that can affect many organs, they predominantly affect the brain and central nervous system. Because the brain is highly metabolically active and neurons cannot easily regenerate, the accumulation of toxic cellular waste caused by lysosomal dysfunction is particularly devastating to brain tissue. The buildup of lipids or complex sugars inside neurons and glial cells leads to progressive neurodegeneration, cognitive decline, loss of motor skills, and structural changes like cortical atrophy. While LSDs as a whole are individually rare, their combined prevalence is roughly 1 in 5,000 to 7,700 live births, and the severe neurological subtypes make up a large portion of these cases.

In a recent landmark study published in Cell, the Abu-Remaileh lab at Stanford University successfully mapped the first quantitative, cell-type-resolved protein atlas of brain lysosomes. They isolated and analyzed lysosomes from the brain's four major cell types: neurons, astrocytes, oligodendrocytes, and microglia. This comprehensive atlas identified dozens of previously uncharacterized lysosomal proteins, revealing that while brain cells share a core set of lysosomal machinery, they also possess distinct, cell-type-specific lysosomal signatures tailored to their unique functional needs.

By applying this atlas, the Abu-Remaileh lab identified SLC45A1 as a strictly neuron-specific lysosomal protein. Mutations in the gene encoding SLC45A1 are known to cause a devastating monogenic neurological disorder characterized by severe intellectual disability and epilepsy. However, prior to this study, had been identified as a SLC45A1 was a sugar importer located on the cell's outer plasma membrane. The Abu-Remaileh lab’s suggested that SLC45A1 was instead a vital lysosomal sugar exporter that clears hexose sugars from the lysosome, and implicated SLC45A1-associated genetic disorders as LSDs.

​In close collaboration with the Stanford Beckman Center Cell Sciences Imaging Facility (CSIF), the Abu-Remaileh lab conducted a series of Transmission Electron Microscopy (TEM) experiments at CSIF to understand the ultrastructure of both human neuroblastoma cells and mouse cortical neurons at a nanometer scale, and to observe the physical impact of SLC45A1 deficiency on lysosome structure. The TEM images revealed striking ultrastructural changes that perfectly mirrored the classical presentation of an LSD. Crucially, TEM captured a defining pathological hallmark: the extensive accumulation of "dense" lysosomes packed with lipofuscin-like pigments. Lipofuscin is a dense, granular material composed of highly oxidized, cross-linked proteins and lipids. In healthy neurons, lysosomes efficiently break down and clear cellular debris. However, the electron micrographs provided undeniable visual proof that in the absence of SLC45A1, neuronal lysosomes structurally fail, transforming into swollen reservoirs of undegraded lipofuscin-like waste. These findings redefine SLC45A1-associated disease as an LSD.

​The Cell Sciences Imaging Facility (CSIF) is a Beckman Center and Stanford Cancer Institute supported university service center that provides high resolution, state-of-the-art light and electron microscopy technologies for imaging and analyzing the molecular and structural organization of cells, tissue and bioengineered materials. For more information, please visit https://microscopy.stanford.edu/